|
× |
 |
GLUCONOLACTONE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EDETATE DISODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
ETHYLCELLULOSES Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EXFORGE HCT (amlodipine besylate; hydrochlorothiazide; valsartan) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
DULERA (formoterol fumarate; mometasone furoate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
|